Related Experiment Video
Updated: Jul 18, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Calpain inhibition stimulates caspase-dependent apoptosis induced by taxol in NIH3T3 cells
David Piñeiro1, M Elena Martín, Natalia Guerra
1Servicio de Bioquímica-Investigación, Hospital Ramón y Cajal, Ctra Colmenar km 9,100, 28034 Madrid, Spain.
Abstract:
Taxol is an anticancer drug that triggers apoptosis in a wide spectrum of cancers such as ovarian, breast, lung, head and neck, and bladder carcinoma by both caspase-dependent and -independent apoptosis mechanisms. However, the exact signaling pathways involved in taxol-induced apoptosis strongly depend on the cellular background and they are not completely established yet. In this study we demonstrate that taxol induces caspase-3-independent apoptosis in NIH3T3 cells by a calpain-mediated mechanism. Taxol treatment produced changes in the mitochondrial membrane potential (Delta Psi m) which could be responsible of Ca(2+) release from the mitochondria and the consequent calpain activation. Interestingly, we show that calpain produced proteolysis of caspase-3 and demonstrate that, accordingly, calpain inhibition increased taxol-induced apoptosis. In addition, we reveal that poly (ADP-ribose) polymerase (PARP) was processed by calpain in taxol-treated cells and by caspase-3 after calpain inhibition. In conclusion, these results demonstrate for the first time that calpain could play an important role modulating taxol-induced apoptosis. Further studies are needed to address the potentiality of inducing apoptosis by a combined use of taxol and calpain inhibitors in cells with increased calpain activity.
Insights
Taxol induces cancer cell death via a calpain-dependent pathway, not relying on caspase-3. Calpain activation leads to caspase-3 proteolysis, influencing taxol
Area of Science:
- Molecular Biology
- Cellular Biology
- Cancer Research
Background:
- Taxol is a widely used anticancer drug that induces apoptosis through caspase-dependent and -independent pathways.
- The precise signaling mechanisms of Taxol-induced apoptosis are cell-type dependent and not fully elucidated.
- Understanding these pathways is crucial for optimizing cancer therapy.
Purpose of the Study:
- To investigate the specific mechanisms of Taxol-induced apoptosis in NIH3T3 cells.
- To determine the role of calpain and caspase-3 in Taxol-mediated cell death.
- To explore the potential of targeting calpain in cancer treatment.
Main Methods:
- Treatment of NIH3T3 cells with Taxol.
- Assessment of mitochondrial membrane potential (Delta Psi m) and calcium ion (Ca(2+)) release.
- Analysis of calpain activation, caspase-3 proteolysis, and poly (ADP-ribose) polymerase (PARP) processing.
- Evaluation of apoptosis induction with and without calpain inhibition.
Main Results:
- Taxol induced caspase-3-independent apoptosis in NIH3T3 cells via a calpain-mediated pathway.
- Taxol treatment altered mitochondrial membrane potential, leading to Ca(2+) release and calpain activation.
- Calpain proteolyzed caspase-3, and calpain inhibition enhanced Taxol-induced apoptosis.
- PARP was processed by calpain in Taxol-treated cells and by caspase-3 upon calpain inhibition.
Conclusions:
- Calpain plays a significant role in modulating Taxol-induced apoptosis.
- The findings suggest a novel mechanism of Taxol action involving calpain activation.
- Combined therapy with Taxol and calpain inhibitors may be a promising strategy for cancers with elevated calpain activity.
Related Concept Videos
Caspases
Drugs that Stabilize Microtubules
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy

